You just read:

Rebiotix Treats First Patient in Phase 1 Study of RBX7455, an Orally Delivered Broad-Spectrum Non-Frozen Microbiota Capsule for Recurrent Clostridium difficile Infection

News provided by

Rebiotix Inc.

Jan 04, 2017, 08:02 ET